Strong Revenue Growth
For the full year 2024, revenue increased by 23.5% to $58.4 million, and adjusted EBITDA increased 43.3% to $9.6 million. Adjusted EBITDA margins improved by 230 basis points to 16.5%.
Patient Affordability Business Success
The patient affordability segment grew 212% year-over-year, reaching $12.7 million in revenue compared to $4.1 million in 2023. Claims processed increased by 272%, and 33 net programs were added, representing a 77% increase over the previous year.
Strategic Acquisition
Paysign announced the acquisition of Gamma Innovation LLC, enhancing their capability to offer integrated solutions for plasma donor and pharmaceutical patient engagement, and marking their entry into the high-margin software-as-a-service market.
Strong Financial Position
Paysign exited the year with $10.8 million in unrestricted cash and zero debt.